Decreased nitric oxide production in chronic viral hepatitis B and C.
Nitric oxide is a free radical gas molecule which may be implicated in antiviral defense. However, there is no information about its possible role in chronic viral hepatitis B and C. In this study we have analyzed the serum levels of NO2- (as an index of nitric oxide generation) from patients with chronic viral hepatitis B and C and relationship of same with the response to interferon therapy. Serum samples were analysed from 61 patients with chronic hepatitis B, 60 patients with chronic hepatitis C, 11 with chronic liver disease of nonviral origin, and 23 healthy controls. Levels of NO2- were statistically higher in healthy controls (P < 0.001) than in patients with chronic liver disease. No relation was found between NO2- and viremia or response to interferon therapy in patients with chronic hepatitis B. In contrast in chronic hepatitis C, responder patients had significantly higher NO2- than nonresponders (P < 0.01). With respect to the relation between NO2- levels and liver damage, patients with cirrhosis had lower NO2- levels than the rest of the patients (P < 0.001). In conclusion, patients with chronic viral hepatitis have low serum NO2- levels.
Amaro
M J
MJ
Hepatology Unit, Fundación Jimenez Diaz, Madrid, Spain.
Bartolomé
J
J
Pardo
M
M
Cotonat
T
T
López-Farré
A
A
Carreño
V
V
D000328:Adult; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000097:blood* / Q000821:virology; D006526:Hepatitis C / Q000097:blood* / Q000821:virology; D006801:Humans; D008099:Liver / Q000293:injuries; D008297:Male; D009569:Nitric Oxide / Q000097:blood*; D009573:Nitrites / Q000097:blood*
D009573:Nitrites; D009569:Nitric Oxide; D002784:Cholesterol